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aortic diseaseCelia V. Riga, MBBS, BSc, Colin D. Bicknell, MD, FRCS, and Nicholas J. W. Cheshire, MD, FRCSThe past 4 decades have witnessed tremendous strides in the evolution of endovascular technology with increased operator
experience, greater availability of more sophisticated and versatile endovascular devices, and advances in imaging modalities.
In an attempt to limit the physiologic derangements associated with aortic crossclamping and extensive tissue dissection
during traditional open surgical repair of extensive thoracoabdominal aortic aneurysms, less invasive strategies have been
explored using endovascular technology: hybrid approaches and solely endovascular techniques. This article describes these
techniques and their advantages, their current role in thoracoabdominal aortic aneurysm repair and potential future develop-
ments in this field. (J Thorac Cardiovasc Surg 2010;140:S168-70)Despite significant advances in surgical techniques, perio-
perative adjuncts, and critical care, the traditional open repair
of extensive disease of the thoracoabdominal aorta (TAA) re-
mains a formidable challenge and is still associated with high
morbidity and mortality rates. Several high-volume institu-
tions have published results that are considered acceptable
when compared with the risk of aneurysm rupture if left un-
treated; these figures, however, are not representative of sur-
gical outcomes worldwide.1 With evolution of endovascular
techniques, less invasive strategies have been developed for
treatment of TAA aneurysms in the hope of decreasing the
extensive morbidity resulting from open aneurysm repair.
Hybrid surgical/endovascular repair with surgical revascu-
larization of aortic branches, stenting of the aneurysmal seg-
ment, and branched/fenestrated approaches to achieve a total
endovascular approach are described herein.
HYBRID SURGERY
Hybrid surgery refers to procedures combining both open
surgical and endovascular techniques. This strategy has been
used in 2 particular areas: (1) the TAA segment and its
branches and (2) aneurysms involving the aortic arch. As
a general principle, extra-anatomic bypass of vital aortic
side branches is followed by stent grafting of the diseased
segment, thus achieving total aneurysm exclusion without
the need for thoracotomy and complete aortic crossclamping.
The Visceral Hybrid Procedure
Our institution described one of the earliest visceral hy-
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nique. Our preferred technical approach for extensive aneu-
rysms that extend into the TAA segment (types I, II, and III)
involves retrograde revascularization of the visceral and re-
nal arteries from the aorta, iliac vessels, or a previous aortic
graft via a transperitoneal approach.
Our first published series of 29 cases showed exceptional
results, with low mortality and no paraplegia.3 However, as
our experience has grown and we have taken on greater
numbers of patients with complex problems, the results are
now more representative of a major surgical procedure in
a high-risk population with atherosclerosis. Our unit has re-
cently reported the largest published series of these repairs
for TAA aneurysms and aortic dissections in 107 high-risk
patients, as a collaborative approach with 2 other major Eu-
ropean centers; we4 observed a 30-day mortality rate of
14.9% and a paraplegia rate of 8.4%. There was a 3.7%
rate of long-term dialysis and a 2.8% rate of gut ischemia.
Graft patency at 30 days was 86.9%. Endoleaks were de-
tected in 29.9% of cases: 56%were type II, and the majority
were managed conservatively.
One of the unanswered questions relating to these extensive
aneurysm repairs using the hybrid strategy is whether to per-
form the operation as a simultaneous or a 2-stage approach.
Our view is that a cold, hypotensive, and coagulopathic pa-
tient who has undergone extensive intra-abdominal dissec-
tion, and who has significant cardiovascular instability,
should not immediately undergo stent grafting inasmuch as
there is a potential for prolonged or recurrent hypotension
and an increased risk of significant paraplegia. In this sce-
nario, it is safer to stabilize the patient and then exclude the
aneurysm during a subsequent procedure. Against this view
are those who cite the risk of interval rupture (which we
have experienced first hand) and the risk of embolic occlusion
of visceral grafts when passing multiple stent grafts through
the iliac segment at a later stage. There is a strong case for
single-stage surgery in patients with large aneurysms who
are stable during the hybrid procedure, especially in those
with access difficulties. Each case needs to be judged on an
individual basis. Stent-graft placement should not be under-
taken at the same time as open surgery unless it is safe to do so.gery c December 2010
Abbreviation and Acronym
TAA ¼ thoracoabdominal aorta
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ous thoracotomy for either cardiac or thoracic aortic surgery,
with 82% of patients in American Society of Anesthesiolo-
gists grade greater than 3 and significant comorbidity, ren-
dering them unfit for an open repair. Taking these adverse
factors into account, we believe this procedure represents
a real advance in the treatment of patients with extensive
TAA aneurysms in our center. Similar results have been re-
ported by others,5 who share the view that in centers with
suitable expertise, the visceral hybrid repair is a viable treat-
ment option for a high-risk patient population with limited
therapeutic alternatives.The Arch Hybrid Procedure
Aortic disease that involves the most proximal descending
thoracic aorta and/or aortic arch may require extra-anatomic
bypasses of the subclavian, brachiocephalic, and carotid ar-
teries with subsequent stenting. There are several graft con-
figurations that may facilitate successful, safe stent grafting
in this area. In patients with aneurysms that necessitate
a proximal landing zone in the arch, complete supra-aortic
revascularization can be performed from the ascending
aorta. A variety of graft configurations may be used: we typ-
ically use a graft to the right carotid artery with a smaller side
branch to the left carotid and a left carotid–subclavian by-
pass. When the aortic disease necessitates graft coverage
of the left subclavian and/or left carotid vessels, a left ca-
rotid–subclavian bypass and/or right-to-left carotid cross-
over is fashioned, respectively, before stenting.
A recently published systematic review of arch hybrid
outcomes in 195 patients showed pooled perioperative mor-
tality and morbidity rates of 9% and 21%, respectively (7%
stroke rate), with a 9% endoleak rate.6 However, most of the
series included in this review contained a small numbers of
patients, increasing the possibility of publication bias. This
is a varied group also in that there are significant differences
between those requiring carotid–subclavian bypass alone
and those requiring full supra-aortic revascularization to fa-
cilitate stent-graft placement. In our experience of 37 such
cases in high-risk patients who require extensive interven-
tion, mortality and morbidity remain significant, especially
in those with concomitant distal aortic disease. We do
believe that the arch hybrid repair provides a feasible
alternative treatment in patients who are at high risk for con-
ventional open surgical repair; however, careful patient
selection and consideration of morphologic features are
essential to achieve satisfactory results.The Journal of Thoracic and CardTOTAL ENDOVASCULAR APPROACH
Although the visceral hybrid repair eliminates the need for
thoracotomy, the results of larger series still suggest a signif-
icant mortality and paraplegia risk. Advances in stent-graft
technology in recent years have allowed the treatment of ex-
tensive aortic disease with custom-made fenestrated and
branched devices, originally designed to extend the proxi-
mal sealing zone in infrarenal disease. Much effort is now
expended in development of this strategy for treatment of an-
eurysms that involve the supra-aortic branches.
Once access has been gained through the groin or via an
iliac conduit, the fenestrated or branched device is placed
at the level of the target vessels under fluoroscopic control,
aligning the fenestrations/branches with the target vessel os-
tium to allow cannulation of the target vessels, subsequent
side-branch stenting, and overall exclusion of the aneurysm.
The efficacy and safety of custom-made fenestrated stents
for the treatment of short-necked infrarenal aneurysms
has been widely described. We7 have demonstrated, with
others,8 encouraging short- and intermediate-term results
for treatment of more extensive aneurysms, with low perio-
perative mortality and morbidity rates and brief hospital
stays in patients with uncomplicated pathologic conditions.
Despite a custom-made device design and extensive pre-
operative planning, graft rotation and misalignment of the
fenestration/vessel ostium interface can still occur. Target
vessel cannulation itself can be technically challenging
and time-consuming even for experienced operators, espe-
cially in the presence of complex tortuous anatomy. Our re-
search at Imperial College has shown definite advantages for
cannulation of vessels using a remotely steerable robotic
catheter system in complex endovascular interventions. In-
tuitive robotic technology has the potential to overcome
some of the limitations of conventional selective catheters,
demonstrating significant reductions in target vessel cannu-
lation times, enhanced accuracy and catheter stability, and
overall improvement in operator performance scores.9
Another primary concern with fenestrated and branched
endografting is the inherent delay in manufacturing owing
to its bespoke nature, which precludes use in ruptured and
urgent cases, even if the anatomic configuration is suitable
for endovascular repair. In situ fenestration may be a poten-
tial solution to this, and several authors have demonstrated
its feasibility using an antegrade or a retrograde approach.10
We11 have found that robotic technology can provide a stable
platform for antegrade in situ fenestration and facilitate the
technique. Further advances in stent-graft design and imag-
ing modalities are essential to make this a viable therapeutic
alternative. Off-the-shelf (non–custom made) branched and
fenestrated devices have also been suggested by several
authors, which may limit the cost of current devices and
expedite treatment,12 but may require significant further
development.iovascular Surgery c Volume 140, Number 6S S169
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As endovascular techniques and technology are con-
stantly improving and evolving, the full impact of fenes-
trated stents and branched grafts on TAA aneurysm repair
is yet to be realized in the context of clinical trials. We be-
lieve that this technology, along with other adjuncts such
as endovascular robotics and dynamic imaging modalities,
represent the future in the management of extensive TAA
disease. However, in the meantime, and in high-risk patients
in whom fenestrated or branched stent grafting is not an op-
tion and open surgery is hazardous, the visceral hybrid rep-
resents a viable, robust, and transferable alternative method
of treating this complex and life-threatening disease process.
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